A detailed history of Dimensional Fund Advisors LP transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Dimensional Fund Advisors LP holds 912,605 shares of RCKT stock, worth $12.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
912,605
Previous 946,175 3.55%
Holding current value
$12.8 Million
Previous $20.4 Million 17.26%
% of portfolio
0.0%
Previous 0.01%

Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

SELL
$17.6 - $25.88 $590,832 - $868,791
-33,570 Reduced 3.55%
912,605 $16.9 Million
Q2 2024

Aug 09, 2024

SELL
$20.66 - $26.72 $1.73 Million - $2.23 Million
-83,613 Reduced 8.12%
946,175 $20.4 Million
Q1 2024

May 10, 2024

SELL
$26.16 - $30.74 $474,882 - $558,023
-18,153 Reduced 1.73%
1,029,788 $27.7 Million
Q4 2023

Feb 07, 2024

SELL
$16.78 - $31.94 $4.84 Million - $9.22 Million
-288,731 Reduced 21.6%
1,047,941 $31.4 Million
Q3 2023

Nov 09, 2023

SELL
$15.07 - $24.05 $37,479 - $59,812
-2,487 Reduced 0.19%
1,336,672 $27.4 Million
Q2 2023

Aug 09, 2023

BUY
$16.59 - $23.6 $1.11 Million - $1.57 Million
66,665 Added 5.24%
1,339,159 $26.6 Million
Q1 2023

May 12, 2023

BUY
$15.79 - $22.6 $2.28 Million - $3.26 Million
144,133 Added 12.77%
1,272,494 $21.8 Million
Q4 2022

Feb 09, 2023

BUY
$15.5 - $22.76 $3.79 Million - $5.57 Million
244,792 Added 27.7%
1,128,361 $22.1 Million
Q3 2022

Nov 10, 2022

BUY
$12.37 - $18.41 $5.52 Million - $8.22 Million
446,574 Added 102.19%
883,569 $14.1 Million
Q2 2022

Aug 12, 2022

BUY
$7.96 - $16.64 $172,970 - $361,587
21,730 Added 5.23%
436,995 $6.01 Million
Q1 2022

May 13, 2022

BUY
$13.16 - $23.68 $379,350 - $682,599
28,826 Added 7.46%
415,265 $6.59 Million
Q4 2021

Feb 09, 2022

BUY
$21.52 - $36.02 $257,874 - $431,627
11,983 Added 3.2%
386,439 $8.44 Million
Q3 2021

Nov 12, 2021

SELL
$27.42 - $48.97 $3.37 Million - $6.02 Million
-122,854 Reduced 24.7%
374,456 $11.2 Million
Q2 2021

Aug 12, 2021

BUY
$39.41 - $47.25 $7.45 Million - $8.93 Million
189,020 Added 61.31%
497,310 $22 Million
Q1 2021

May 14, 2021

SELL
$43.34 - $65.91 $1.2 Million - $1.83 Million
-27,716 Reduced 8.25%
308,290 $13.7 Million
Q4 2020

Feb 25, 2021

BUY
$23.3 - $59.57 $7.83 Million - $20 Million
336,006 New
336,006 $18.4 Million

Others Institutions Holding RCKT

About ROCKET PHARMACEUTICALS, INC.


  • Ticker RCKT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 75,683,696
  • Market Cap $1.06B
  • Description
  • Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...
More about RCKT
Track This Portfolio

Track Dimensional Fund Advisors LP Portfolio

Follow Dimensional Fund Advisors LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

News

Stay updated on Dimensional Fund Advisors LP with notifications on news.